Home

Robert Berman

CIK 1704483 · Special Projects & Med Ovrsght · last filed 2020-07-10

Robert Berman is a Special Projects & Med Ovrsght who has filed 20 SEC Form 4 insider transactions across 1 company since 2017. The most recent filing, for BHVN, was dated Jul 10, 2020. Across all open-market trades the lifetime net is −$33.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.6M across reported positions. 23 SEC filings were submitted jointly with Biohaven Pharmaceutical Holding Co Ltd.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.63M

Companies

1

Total Filings

20

Lifetime Open-Market Net

-$33.23M

Filer Profile

Reported Address
C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP
234 CHURCH STREET
NEW HAVEN, CT 06510
Related Filers
Biohaven Pharmaceutical Holding Co Ltd. — 23 joint filings, latest 2020-07-10
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BHVN Special Projects & Med Ovrsght 550,341 $15.69 $8.63M -$33.23M 20 2020-07-10

Recent Filings

20 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-07-10 BHVN Mixed — -$4.36M EDGAR
2020-06-25 BHVN Mixed — -$319.8K EDGAR
2020-06-22 BHVN Mixed — -$4.53M EDGAR
2019-12-31 BHVN Mixed — -$6.58M EDGAR
2019-12-20 BHVN Mixed +341 -$14.8K EDGAR
2019-11-27 BHVN Grant (A) — $0 EDGAR
2019-06-28 BHVN Buy (P) +2,500 $105.8K EDGAR
2018-06-20 BHVN Sell (S) −76,692 -$2.79M EDGAR
2018-06-12 BHVN Sell (S) −104,155 -$3.78M EDGAR
2018-06-07 BHVN Sell (S) −25,845 -$930.7K EDGAR
Showing 1–10 of 20
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.